The Engine Accelerator’s Post

#Webinar now available on demand! Salt-tolerant #endonucleases and the benefits for #viralvectormanufacturing, and a comparison of two marketed #enzymes To further improve the production efficacy of #viravectors, higher salt concentrations can be applied, but as a result, this may inhibit the function of endonucleases, which causes challenges. c-LEcta GmbH's Marc Struhalla (CEO) and Svenja Michalek (Product Manager Biopharma) introduce a novel engineered variant of the Serratia marcescens wild-type enzyme, which is more tolerant to higher salt concentrations and can streamline the viral #vectormanufacturing process. Data generated by a cell and #genetherapy #CDMO who compared DENARASE® High Salt with another commercially available salt-tolerant endonuclease (SAN HQ) in an AAV2 harvest is be presented Watch at your convenience below:

SymBiosis is excited to invest in Aardvark Therapeutics' $85 million oversubscribed Series C financing after an ongoing trial of the company’s lead asset, ARD-101, in young adults with Prader-Willi Syndrome showed marked decreases in hunger and food-seeking behavior in several treated individuals. ARD-101 is a first-in-class bitter taste receptor agonist that reduces hunger through the selective induction of gut-brain signaling. With this financing, Aardvark is now funded through both a potential regulatory approval for ARD-101 and a potential demonstration of ARD-101’s complementary mechanism of action to GLP-1 therapies in treating obesity and metabolic diseases.   Read more here: https://lnkd.in/gR8aS9nw   #VentureCapital #Biotechnology #PortfolioCompany

🔜 One more day until #BioTrinity! I am looking forward to meeting up with as many people as I can in the drug development space, and discussing their requirements for Bioanalysis and how A4PBio can assist with. 💊 💉 📩 ☎ If you are attending and would like to meet for a chat, drop me a message and I would be delighted to arrange a time! #bioanalysis #drugdevelopment #projectmanagement #biotrinity

Are you planning a clinical or preclinical study for your next innovation? Over the last 22 years, we've helped a large number of companies develop award-winning probiotics, postbiotics, prebiotics and even synbiotics through clinical trials! Jayesh Chaudhary and Anuj Chipkar will be at #Probiota in #Milan this week. Grab this opportunity to ask them questions about our latest experiences and new offerings. #probiotics #tradeshow #europe #clinicalresearch #clinicaltrials

#Animal_Model Market is estimated to grow at a high CAGR >> https://lnkd.in/gwsmUu7D The report on the global #Animal #Model Market evaluates the #growth #trends of the industry through historical study and estimates prospects based on comprehensive #research. The report extensively provides the market #demand, share, growth, trends, and #forecasts for the period 2023-2032. Charles River Laboratories, Envigo AB, genOway Harlan Laboratories, Inc., JANVIER LABS, SAGE® Labs, Taconic Biosciences TRANSGENIC LTD, Transposagen Biopharmaceuticals #animalmodel #biotechnology #science #laboratory #researchreport #growth

Explore the unique challenges and essential insights for biologic therapies, in this article from Singota Solutions. 💡 #BiologicTherapies #ManufacturingChallenges #AsepticFilling #SmallBatch #FormulaationDevelopment

Addressing Unique Challenges - Essential Insights for Biological Therapies. Singota Solutions is here!

🌻Sunflower Therapeutics Revolutionizes Global Biotech with Small Footprint Manufacturing Excellent episode of Talking Biotech Podcast with Kevin Folta and Dr. Kerry Love. It delves into transforming the biotech landscape by making protein-based therapeutics more accessible worldwide. Her vision demonstrates how we can address healthcare disparities by empowering regions to create and control their own biotech solutions. "When you enable in-region creation of a product for the region, you're helping to co-create a better product with regional scientists." #DYK that Africa is the most genetically diverse continent on earth and that 15% of Africans who receive a biologic drug go to the hospital because of negative side effects? Sunflower plans to change this. Tune in to the full podcast for an in-depth discussion on the future of distributed manufacturing and its potential to transform global health. 🎧 #Biotech #Innovation #Manufacturing #Vaccines #Cosmetics #InfectiousDisease #Healthcare

In the sixth instalment of Citeline Commercial’s #ScripAsks annual series, which features insights from executives and experts on key questions affecting the biopharma industry, our CEO, Neil Weir, expresses his optimism on recent autoimmune and inflammatory disease breakthroughs, and how this is paving the way for the discovery of new therapeutic targets to address a significant unmet need.   Read the full article here: https://lnkd.in/eNRMWRb8   #Biotech #CellMetabolism #DrugDiscovery #DrugDevelopment #Immunometabolism #Biotechnology

I am excited to share the latest educational video on the work Temple Street Biotech, one of our portfolio companies, is doing in an attempt to hault the horrible outcomes of Alzheimer’s Disease. See link below. #Alzheimer’s #biotech #neurodegenerativedisease #pharma #yale #templestreetbiotech